FrancophonIA/ELRC3.0 huggingface dataset:
English: Docetaxel is a lipophilic substance but it is not known whether it is excreted in human milk.
Slovenian: Docetaxel je lipofilna snov, vendar ni znano , ali se izloča v materino mleko.
English: 95% CI p-valuea* a Time to event variables: Stratified log-rank test.
Slovenian: Vrednost pa* a Spremenljivke časa do dogodka: stratificirani log-rang test.
English: Exploratory subgroup analyses for disease-free survival for patients who meet the 2009 St. Gallen chemotherapy criteria - (ITT population) were performed and presented here below:
Slovenian: Opravljene so bile eksplorativne analize podskupin glede preživetja brez bolezni pri bolnicah, ki izpolnjujejo St.-Gallenska merila 2009 za kemoterapijo (populacija ZNZ); predstavljene so spodaj:
English: If the vials are stored under refrigeration, allow the required number of boxes of Docetaxel Zentiva concentrate for solution for infusion to stand below 25°C for 5 minutes before use.
Slovenian: Če so viale shranjene v hladilniku, pustite potrebno število škatel koncentrata za raztopino za infundiranje zdravila Docetaxel Zentiva pred uporabo 5 minut stati na temperaturi do 25°C.
English: This regimen was administered every three weeks for 4 cycles in case at least a minor response (≥ 25% reduction in bidimensionally measured tumour size) was observed after 2 cycles.
Slovenian: To terapevtsko shemo so uporabljali vsake tri tedne za 4 cikle, če so po 2 ciklih opazili vsaj manjši odziv ( ≥ 25 % zmanjšanje dvodimenzionalno merjene velikosti tumorja).
English: The incidence of serious adverse events was higher in the older people compared to younger patients.
Slovenian: Incidenca resnih neželenih učinkov je bila pri starejših bolnikih večja kot pri mlajših.
English: Docetaxel1 n = 94
Slovenian: docetaksel 1 n = 94
English: Docetaxel Zentiva must NOT be administered if you are pregnant unless clearly indicated by your doctor.
Slovenian: Zdravila Docetaxel Zentiva NE smete dobiti, če ste noseči, razen če vam vaš zdravnik ne odredi drugače.
English: Discuss with your doctor if you suffer from alcohol dependency, epilepsy or liver impairment.
Slovenian: Posvetujte se z zdravnikom, če ste odvisni od alkohola, imate epilepsijo ali okvaro jeter.
English: The most commonly reported adverse reactions of Docetaxel Zentiva alone are: decrease in the number of red blood cells or white blood cells, alopecia, nausea, vomiting, sores in the mouth, diarrhoea and tiredness.
Slovenian: Najpogosteje poročani neželeni učinki zdravila Docetaxel Zentiva samega so: zmanjšanje števila rdečih ali belih krvnih celic, alopecija, slabost, bruhanje, razjede v ustih, driska in utrujenost.
English: What Docetaxel Zentiva is and what it is used for
Slovenian: Kaj je zdravilo Docetaxel Zentiva in za kaj ga uporabljamo
English: If the concomitant use of a strong CYP3A4 inhibitor (e.g., ketoconazole, itraconazole, clarithromycin, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin and voriconazole) cannot be avoided, a close clinical surveillance is warranted and a dose-adjustment of docetaxel may be suitable during the treatment with the strong CYP3A4 inhibitor (see section 4.4).
Slovenian: Če se sočasni uporabi močnega zaviralca CYP3A4 (npr. ketokonazola, itrakonazola, klaritromicina, indinavirja, nefazodona, nelfinavirja, ritonavirja, sakvinavirja, telitromicina in vorikonazola) ni mogoče izogniti, je potreben natančen klinični nadzor in med zdravljenjem z močnim zaviralcem CYP3A4 je lahko primerna prilagoditev odmerka docetaksela (glejte poglavje 4.4).
English: METHOD AND ROUTE(S) OF ADMINISTRATION Ready to add to infusion solution.
Slovenian: POSTOPEK IN POT(I) UPORABE ZDRAVILA Pripravljeno za dodatek raztopini za infundiranje.
English: Docetaxel Zentiva contains alcohol.
Slovenian: Zdravilo Docetaxel Zentiva vsebuje alkohol.
English: Symptomatic cardiac failure was reported in 2.2% of the patients who received docetaxel plus trastuzumab compared to 0% of patients given docetaxel alone.
Slovenian: O simptomatskem srčnem popuščanju so poročali pri 2,2 % bolnikov, ki so dobivali docetaxel in trastuzumab, in pri 0 % bolnikov, ki so dobivali samo docetaxel.
English: România S.C. ZENTIVA S.A.
Slovenian: S.C. ZENTIVA S.A.
English: Docetaxel every 3 weeks
Slovenian: Končna točka docetaxel vsake 3 tedne docetaxel vsak teden
English: • 1276 patients (744 and 532 in TAX 316 and GEICAM 9805 respectively) who received docetaxel in combination with doxorubicin and cyclophosphamide (clinically important treatment related adverse events are presented).
Slovenian: • 1276 bolnikih (744 v TAX 316 in 532 GEICAM 9805), ki so prejemali docetaksel v kombinaciji z doksorubicinom in ciklofosfamidom (predstavljeni so klinično pomembni z zdravljenjem povezani neželeni učinki).
English: Prophylactic G-CSF may be used to mitigate the risk of haematological toxicities.
Slovenian: Za zmanjšanje nevarnosti hematološke toksičnosti se lahko uporablja profilaktično G-CSF.
English: You must not be given Docetaxel Zentiva:
Slovenian: Zdravila Docetaxel Zentiva ne smete dobiti:
English: Docetaxel Zentiva has been prescribed by your doctor for the treatment of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric cancer or head and neck cancer: - For the treatment of advanced breast cancer, Docetaxel Zentiva could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.
Slovenian: Zdravnik vam je zdravilo Docetaxel Zentiva predpisal za zdravljenje raka dojke, posebne vrste pljučnega raka (nedrobnocelični pljučni rak), raka prostate, raka želodca ali raka glave in vratu: - Za zdravljenje napredovalega raka dojke se lahko zdravilo Docetaxel Zentiva uporablja sam ali v kombinaciji z doksorubicinom ali trastuzumabom ali kapecitabinom.
English: Like all medicines, this medicine can cause side effects, although not everybody gets them.
Slovenian: Tako kot vsa zdravila , ima lahko tudi to zdravilo neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: Tel: +40 021 304 7597
Slovenian: Tel: +40 021 304 7597 PV
English: You must not become pregnant during treatment with this medicine and must use an effective method of contraception during therapy, because Docetaxel Zentiva may be harmful for the unborn baby.
Slovenian: Med zdravljenjem z zdravilom Docetaxel Zentiva ne smete zanositi in morate uporabljati učinkovito kontracepcijsko zaščito, ker zdravilo Docetaxel Zentiva lahko škoduje vašemu nerojenemu otroku.
English: The pharmacokinetic profile of cisplatin administered shortly after docetaxel infusion is similar to that observed with cisplatin alone.
Slovenian: Farmakokinetični profil cisplatina, uporabljenega kmalu po infuziji docetaxel, je podoben kot po uporabi samega cisplatina.
English: Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Slovenian: izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
English: The median TTP was 37.3 weeks (95% CI: 33.4 - 42.1) in AT arm and 31.9 weeks (95% CI: 27.4 - 36.0) in AC arm.
Slovenian: Mediana časa do napredovanja je bila v kraku AT 37,3 tedna (95 % IZ: 33,4 - 42,1) in v kraku AC 31,9 tedna (95 % IZ: 27,4 - 36,0).
English: What Docetaxel Zentiva contains - The active substance is docetaxel (as trihydrate).
Slovenian: Kaj vsebuje zdravilo Docetaxel Zentiva - Zdravilna učinkovina je docetaksel (v obliki trihidrata).
English: See also section “Docetaxel Zentiva contains ethanol (alcohol)” below.
Slovenian: Glejte tudi poglavje »Zdravilo Docetaxel Zentiva vsebuje etanol (alkohol)«.
English: Marketing Authorisation Holder Zentiva k.s.
Slovenian: Imetnik dovoljenja za promet z zdravilom Zentiva k.s.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Docetaxel Zentiva in all subsets of the paediatric population in breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila (EMA) je odstopila od obveze za predložitev rezultatov študij z zdravilom Docetaxel Zentiva za vse skupine pediatrične populacije za raka dojke, nedrobnoceličnega pljučnega raka, raka prostate, karcinom želodca in raka glave in vratu, ne vključujoč manj diferenciiran nazofaringealni karcinom tipa II oz. III (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: As with all parenteral products, Docetaxel Zentiva infusion solution should be visually inspected prior to use, solutions containing a precipitate should be discarded.
Slovenian: Tako kot vsa zdravila za parenteralno uporabo je treba tudi raztopino za infundiranje zdravila Docetaxel Zentiva pred uporabo pregledati; če vsebuje precipitat, jo je treba zavreči.
English: permanent hair loss has been observed
Slovenian: (pogostnost neznana) so opazili trajno izgubo las.
English: For combination with capecitabine, the most frequent treatment-related undesirable effects (≥ 5%) reported in a phase III study in breast cancer patients failing anthracycline treatment are presented (see capecitabine summary of product characteristics).
Slovenian: Pri kombinaciji s kapecitabinom so predstavljeni najpogostejši z zdravljenjem povezani neželeni učinki (≥ 5 %), o katerih so poročali v študiji III. faze pri bolnicah z rakom dojke z neuspelim zdravljenjem z antraciklini (prosimo, glejte povzetek glavnih značilnosti kapecitabina).
English: If you are a man being treated with Docetaxel Zentiva you are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because docetaxel may alter male fertility.
Slovenian: Če ste moški, ki se zdravi z zdravilom Docetaxel Zentiva je priporočljivo, da ne zaplodite otroka med zdravljenjem in v obdobju 6 mesecev po koncu zdravljenja ter da pred začetkom zdravljenja poiščete nasvet glede ohranitve sperme, ker docetaksel lahko prizadene moško plodnost.
English: In patients who were 75 years of age or older, when compared to younger patients, neutropenia, anemia, diarrhea, dyspnea and upper respiratory tract infection were reported with a greater incidence (at least 10% higher).
Slovenian: Bolniki, stari 75 let ali več, so imeli v primerjavi z mlajšimi bolniki večjo (vsaj 10 % večjo) pojavnost nevtropenije, anemije, driske, dispneje in okužb zgornjih dihal.
English: Each vial of concentrate contains 0.5 ml of ethanol anhydrous (395 mg).
Slovenian: Vsaka viala koncentrata vsebuje 0,5 ml brezvodnega etanola (395 mg).
English: What you need to know before you use Docetaxel Zentiva
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Docetaxel Zentiva
English: Based on a population pharmacokinetic analysis, there are no special instructions for use in the older people.
Slovenian: Za uporabo pri starostnikih glede na analizo farmakokinetike na populaciji ni posebnih navodil.
English: For patients who are dosed initially at docetaxel 75 mg/m2 in combination with cisplatin and whose nadir of platelet count during the previous course of therapy is < 25,000 cells/mm3, or in patients who experience febrile neutropenia, or in patients with serious non-haematologic toxicities, the docetaxel dose in subsequent cycles should be reduced to 65 mg/m2.
Slovenian: V kombinaciji s cisplatinom Bolnikom, ki uvodoma dobijo docetaksel v odmerku 75 mg/m2 v kombinaciji s cisplatinom in imajo v predhodnem ciklusu zdravljenja najmanjše število trombocitov < 25.000 celic/mm3, bolnikom, ki doživijo febrilno nevtropenijo, in bolnikom z resnimi nehematološkimi toksičnimi učinki je treba odmerek docetaksela v naslednjih ciklusih zmanjšati na 65 mg/m2.
English: Efficacy of docetaxel in the treatment of patients with gastric adenocarcinoma
Slovenian: Učinkovitost docetaxela pri zdravljenju bolnikov z adenokarcinomom želodca
English: For combination with ADT and with prednisone or prednisolone (STAMPEDE study), adverse events occurring over the 6 cycles of treatment with docetaxel and having at least 2% higher incidence in the docetaxel treatment arm by comparison to the control arm, are presented, using the CTCAE grading scale.
Slovenian: Za kombinacijo z ADT in prednizonom ali prednizolonom (študija STAMPEDE) so prikazani neželeni učinki, ki so se pojavili v 6 ciklusih zdravljenja z docetakselom in so imeli v skupini z docetakselom vsaj 2 % večjo pojavnost kot v kontrolni skupini; uporabljena je lestvica stopenj CTCAE.
English: The name of this medicine is Docetaxel Zentiva.
Slovenian: To zdravilo se imenuje Docetaxel Zentiva.
English: Other medicines and Docetaxel Zentiva
Slovenian: Druga zdravila in zdravilo Docetaxel Zentiva
English: Docetaxel Zentiva in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.
Slovenian: Zdravilo Docetaxel Zentiva je v kombinaciji s cisplatinom in 5-fluorouracilom indiciran za indukcijsko zdravljenje bolnikov z lokalno napredovalim skvamoznoceličnim karcinomom glave in vratu.
English: The ORR was 59.3% (95% CI: 52.8 - 65.9) in AT arm versus 46.5% (95% CI: 39.8 - 53.2) in AC arm.
Slovenian: V kraku AT je bil celotni delež odziva 59,3 % (95 % IZ: 52,8 - 65,9) in v kraku AC 46,5 % (95 % IZ: 39,8
English: Patients who experience febrile neutropenia and/or neutropenic infection should have their docetaxel dose reduced to 60 mg/m² in all subsequent cycles (see sections 4.4 and 4.8).
Slovenian: Bolnikom, ki se jim pojavi febrilna nevtropenija in/ali nevtropenična okužba, je treba odmerek docetaksela v vseh nadaljnjih ciklusih zmanjšati na 60 mg/m2 (glejte poglavji 4.4 in 4.8).
English: Metastatic hormone-sensitive prostate cancer The recommended dose of docetaxel is 75 mg/m2 every 3 weeks for 6 cycles.
Slovenian: Metastatski, hormonsko občutljiv rak prostate Priporočeni odmerek docetaksela je 75 mg/m2 na 3 tedne 6 ciklusov.
English: Prednisone and dexamethasone
Slovenian: Prednison in deksametazon
English: It is important that you read the entire contents of this guide prior to the preparation of the Docetaxel Zentiva infusion solution.
Slovenian: Pomembno je, da pred pripravo osnovne raztopine zdravila Docetaxel Zentiva ali raztopine za infundiranje zdravila Docetaxel Zentiva v celoti preberete ta navodila.
English: OTHER Contains anhydrous ethanol (see leaflet)
Slovenian: DRUGI PODATKI Vsebuje brezvodni etanol (glejte navodilo za uporabo)
English: • 332 patients (TAX327) who received docetaxel in combination with prednisone or prednisolone (clinically important treatment related adverse events are presented).
Slovenian: • 332 bolnikih (TAX 327), ki so prejemali docetaksel v kombinaciji s prednizonom ali prednizolonom (predstavljeni so klinično pomembni z zdravljenjem povezani neželeni učinki).
English: From a microbiological point of view, reconstitution/dilution must take place in controlled and aseptic conditions.
Slovenian: Z mikrobiološkega stališča mora biti rekonstitucija/redčenje opravljeno v nadzarovanih in preverjenih aseptičnih pogojih.
English: Myelodysplastic syndrome was reported in 2 of 744 TAC patients (0.3%) and in 1 of 736 FAC patients (0.1%).
Slovenian: Mielodisplastični sindrom so zabeležili pri 2 od 744 bolnic, ki so prejemale TAC (0,3%), in pri 1 od 736 bolnic, ki so prejemale FAC (0,1%).
English: TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophosphamide CI = confidence interval; ER = oestrogen receptor PR = progesterone receptor a ER/PR-negative or Grade 3 or tumour size >5 cm
Slovenian: TAC = docetaksel, doksorubicin in ciklofosfamid FAC = 5-fluorouracil, doksorubicin in ciklofosfamid IZ = interval zaupanja, ER = estrogenski receptor PR = progesteronski receptor a negativno ER/PR ali 3. stopnja ali velikost tumorja > 5 cm
English: Cautions for use in castration-resistant prostate cancer Of the 333 patients treated with docetaxel every three weeks in a prostate cancer study (TAX 327), 209 patients were 65 years of age or greater and 68 patients were older than 75 years.
Slovenian: Previdnost pri uporabi pri raku prostate, odpornem proti kastraciji Od 333 bolnikov z rakom prostate v študiji, ki so bili zdravljeni z docetakselom vsake tri tedne, je bilo 209 bolnikov starih 65 let ali več, 68 bolnikov pa je bilo starih nad 75 let.
English: PSA response** at 12 months - N(%) p-valuea*
Slovenian: Odziv PSA** po 12 mesecih - N (%)
English: Each vial of concentrate contains 2 ml of ethanol anhydrous (1.58 g).
Slovenian: Vsaka viala koncentrata vsebuje 2 ml brezvodnega etanola (1,58 g).
English: Consequently, because of the potential for adverse reactions in nursing infants, breast-feeding must be discontinued for the duration of docetaxel therapy.
Slovenian: Zaradi možnih neželenih učinkov na dojenčke je treba dojenje med zdravljenjem z docetakselom prekiniti.
English: Cautions for use in hormone-sensitive prostate cancer Of the 545 patients treated with docetaxel every 3 weeks in a hormone-sensitive prostate cancer study (STAMPEDE), 296 patients were 65 years of age or older, and 48 patients were 75 years of age or older.
Slovenian: Previdnost pri uporabi pri hormonsko občutljivem raku prostate Od 545 bolnikov, ki so bili v študiji hormonsko občutljivega raka prostate (študija STAMPEDE) zdravljeni z docetakselom na 3 tedne, je bilo 296 bolnikov starih 65 let ali več in 48 bolnikov 75 let ali več.
English: More patients aged ≥65 years in the docetaxel arm reported hypersensitivity reaction, neutropenia, anemia, fluid retention, dyspnea, and nail changes when compared to the patients aged less than 65 years.
Slovenian: V skupini, ki je prejemala docetaksel, je o preobčutljivostni reakciji, nevtropeniji, anemiji, zadrževanju tekočine, dispneji in spremembi nohtov poročalo več bolnikov, starih ≥ 65 let, kot bolnikov, mlajših od 65 let.
English: After 10 years of follow up in study TAX316, acute leukaemia was reported in 3 of 744 TAC patients (0.4%) and in 1 of 736 FAC patients (0.1%).
Slovenian: Po 10 letih spremljanja v študiji TAX316 so akutno levkemijo zabeležili pri 3 od 744 bolnic, ki so prejemale TAC (0,4%), in pri 1 od 736 bolnic, ki so prejemale FAC (0,1%).
English: • From a microbiological point of view, reconstitution /dilution must take place in controlled and aseptic conditions and the infusion solution should be used immediately.
Slovenian: • Z mikrobiološkega stališča mora biti rekonstitucija/redčenje opravljeno v nadzarovanih in preverjenih aseptičnih pogojih in raztopino za infundiranje je treba uporabiti takoj.
English: If Docetaxel Zentiva concentrate or infusion solution should come into contact with skin, wash immediately and thoroughly with soap and water.
Slovenian: Če pride koncentrat ali raztopina za infundiranje zdravila Docetaxel Zentiva v stik s kožo, jo je treba takoj in temeljito umiti z milom in vodo.
English: • Docetaxel 30 mg/m2 administered weekly for the first 5 weeks in a 6 week cycle for 5 cycles.
Slovenian: • Docetaxel 30 mg/m2 aplicirano tedensko prvih 5 tednov 6 tedenskega cikla, ki se ponovi v 5-ih ciklih.
English: • 174 and 251 head and neck cancer patients who received docetaxel in combination with cisplatin and 5-fluorouracil (clinically important treatment related adverse events are presented).
Slovenian: • 174 in 251 bolnikih z rakom glave in vratu, ki so prejemali docetaksel v kombinaciji s cisplatinom in 5-fluorouracilom ( navedeni so klinično pomembni, z zdravljenjem povezani, neželeni učinki).
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMA) http://www.ema.europa.eu/
English: Based on pharmacokinetic data with docetaxel at 100 mg/m² as single agent, patients who have both elevations of transaminase (ALT and/or AST) greater than 1.5 times the upper limit of the normal range (ULN) and alkaline phosphatase greater than 2.5 times the ULN, the recommended dose of docetaxel is 75 mg/m2 (see sections 4.4 and 5.2).
Slovenian: Bolniki z okvaro jeter Glede na farmakokinetične podatke o monoterapiji z docetakselom v odmerku 100 mg/m2 je priporočljivi odmerek docetaksela za bolnike, ki imajo transaminazi (ALT, AST ali obe) zvišani nad 1,5-kratno zgornjo mejo normalnega območja (ULN) in alkalno fosfatazo nad 2,5-kratno ULN, 75 mg/m2 (glejte poglavji 4.4 in 5.2).
English: PSA response** at 6 months - N(%) p-valuea*
Slovenian: Odziv PSA** po 6 mesecih - N (%)
English: As the benefit observed in patient with 4+ nodes was not statistically significant on disease-free survival (DFS) and overall survival (OS), the positive benefit/risk ratio for TAC in patients with 4+ nodes was not fully demontrated at the final analysis (see section 5.1).
Slovenian: Za preživetje brez bolezni (DFS - disease-free survival) in celokupno preživetje (OS - overall survival) ugotovljena korist pri bolnicah z bezgavkami 4+ ni bila statistično značilna, zato končna analiza ni v celoti potrdila pozitivnega razmerja med koristjo in tveganjem TAC pri bolnicah z bezgavkami 4+ (glejte poglavje 5.1).
English: In case CMO is diagnosed, docetaxel treatment should be discontinued and appropriate treatment initiated (see section
Slovenian: Ce je diagnosticiran CMO, je treba zdravljenje z docetakselom prekiniti in uvesti ustrezno zdravljenje (glejte poglavje 4.8).
English: If Docetaxel Zentiva concentrate or infusion solution should come into contact with mucous membranes, wash immediately and thoroughly with water.
Slovenian: Če pride koncentrat ali raztopina za infundiranje zdravila Docetaxel Zentiva v stik s sluznicami, jih je treba takoj in temeljito umiti z vodo.
English: There is no relevant use of Docetaxel Zentiva in the paediatric population in the indications breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma.
Slovenian: Zdravilo Docetaxel Zentiva ni primerno za uporabo pri pediatrični populaciji za indikacije rak dojke, nedrobnocelični pljučni rak, rak prostate, karcinom želodca in rak glave in vratu, ne vključujoč manj diferenciiran nazofaringealni karcinom tipa II oz. III.
English: • Then, inject via a single injection (one shot) into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Slovenian: • Potem jo vbrizgajte preko ene injekcije (en odmerek) v 250-ml infuzijsko vrečko ali steklenico, ki vsebuje 5 % raztopino glukoze ali raztopino natrijevega klorida 9 mg/ml (0,9 %) za injiciranje.
English: You must not breast-feed while you are treated with Docetaxel Zentiva.
Slovenian: Med zdravljenjem z zdravilom Docetaxel Zentiva ne smete dojiti.
English: Docetaxel Zentiva contains ethanol (alcohol)
Slovenian: Zdravilo Docetaxel Zentiva vsebuje etanol (alkohol).
English: Each vial of concentrate contains 4 ml of ethanol anhydrous (3.16 g).
Slovenian: Ena viala koncentrata vsebuje 4 ml brezvodnega etanola (3,16 g).
English: The severity of adverse events of Docetaxel Zentiva may be increased when Docetaxel Zentiva is given in combination with other chemotherapeutic agents.
Slovenian: Izrazitost neželenih učinkov zdravila Docetaxel Zentiva se lahko poveča, če dobivate zdravilo Docetaxel Zentiva v kombinaciji z drugimi kemoterapevtiki.